Published in Hepatitis Weekly, February 17th, 1997
In a study conducted by the manufacturer, SmithKline Beecham Biologicals (Rixensart, Belgium), the vaccines elicited mild local adverse effects in the majority of patients and general flu-like symptoms in just under one-third of the study's 20 subjects.
These findings were presented by M. Wettendorff at the International Business Communications' conference, "Hepatitis: Latest Therapeutic Developments for Hepatitis B and C," held January 30-31, 1997 in Washington D.C.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.